ロード中...
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
Tumour-associated KRAS mutations are the most prevalent in the three RAS-family isoforms and involve many different amino-acids. Therefore, molecules able to interfere with mutant KRAS protein are potentially important for wide-ranging tumour therapy. We describe the engineering of two RAS degraders...
保存先:
| 出版年: | Nat Commun |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319959/ https://ncbi.nlm.nih.gov/pubmed/32591521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-17022-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|